NAD+ Catalog Comparison Notes — this article examines published research context, laboratory applications, and procurement notes for NAD+ (100mg / 500mg / 1000mg) in Mitochondrial Research programs at Sulan Peptide Official.
NAD+ is nicotinamide adenine dinucleotide used in laboratory research on cellular redox systems, mitochondrial pathway models, coenzyme-dependent reactions, and metabolic signaling studies.
Sulan Peptide lists NAD+ in the Mitochondrial Research category for buyers reviewing cellular redox and coenzyme-related research products, available formats, Cat No. details, and structured quotation information.
Available NAD+ formats include 100mg, 500mg, and 1000mg options. The product page provides molecular specifications, purity target, appearance, storage guidance, pricing references, and quote-cart support for research-use procurement.
100mg, 500mg, or 1000mg per kit, as selected
Research tracks NAD+/NADH ratios during aging cell models and reprogramming experiments requiring defined coenzyme concentrations.
Enzymatic cycling assays, sirtuin activity kits with acetylated peptide substrates, and LC-MS metabolomics quantify NAD+ pool dynamics.
Sinclair lab and broader aging research literature use NAD+ precursors and NAD+ itself to probe sirtuin-dependent stress responses in cell models.
NAD+ serves as coenzyme for sirtuins, PARPs, and redox enzymes; exogenous NAD+ in culture supports sirtuin deacetylase activity assays and mitochondrial respiration studies.
Catalog comparison: When evaluating NAD+ within Mitochondrial Research, compare vial format (100mg / 500mg / 1000mg), documented purity, and COA availability—not product names alone.
Related catalog items in the same research direction include Glutathione, Mots-C, SS-31. Open parallel product tabs and export specification fields before leadership approval.
Blend kits versus single-peptide vials serve different experimental designs; confirm protocol requirements before selecting NAD+ over alternatives.
Shipping seasonality can affect lyophilized cake integrity for NAD+; inspect vials after extreme transit delays even if COA predates shipment.
Training records for staff handling NAD+ should cover reconstitution math, RUO policy, and spill cleanup for research laboratories.
Network meta-analyses in Mitochondrial Research rarely include identical NAD+ specifications—match mg strength when citing external effect sizes.
Price-per-mg comparisons for NAD+ should include documentation and shipping costs, not vial price alone.
Dose–response studies with NAD+ typically span log-scale concentrations; your protocol should state whether dosing is by mass (100mg / 500mg / 1000mg) or molarity derived from molecular weight on the product page.
Published Mitochondrial Research papers often include positive and negative assay controls alongside NAD+; budget control compounds before ordering experimental material.
When designing multi-arm studies, randomize vial lot assignment and blind analysts to supplier identity until primary readouts are locked—this reduces bias in vendor comparison experiments involving NAD+.
Literature searches for NAD+ should use both trade names and CAS 53-84-9 to capture mechanistic papers missed by supplier marketing keywords alone.
Catalog specification data for NAD+ lists CAS 53-84-9, Molecular formula C21H27N7O14P2. molecular weight 663.4 g/mol, and purity target ≥ 99.0%. Match these identifiers to incoming COA documents and internal sample labels before assay use.
Supplier storage guidance for NAD+: Store at -20°C, in a cool and dry place. Log receipt date, lot number, and freezer location when material enters your inventory. Plan aliquots before reconstitution to limit freeze-thaw cycles during multi-week assay series.
Available NAD+ research formats on sulanpeptide.shop include 100mg10vials, 500mg10vials, 1000mg*10vials. Cat No. references (NJ100, NJ500, NJ1000) should appear on requisitions so quoted material matches the specification selected during protocol design.
When NAD+ appears in combination with other peptides, cite each sequence’s Cat No. in publications to satisfy reproducibility standards in Mitochondrial Research journals.
Statistical plans should pre-register primary endpoints before unblinding NAD+ treatment arms in preclinical models.
Pilot experiments with NAD+ often start at mid-range catalog specifications (100mg / 500mg / 1000mg) before scaling quantity for full study cohorts.
Cell viability panels should precede mechanism assays when introducing NAD+ to new cell lines—unexpected toxicity may reflect solvent choice rather than peptide sequence.
For long-horizon Mitochondrial Research projects, document freezer location and thaw count on every aliquot label tied to NAD+ lot numbers.
Appearance notes (White Lyophilized Powder) help detect moisture exposure or handling damage during receiving inspection of NAD+.
Internal IRB or IACUC protocols should cite RUO scope explicitly when NAD+ appears in animal or human-derived tissue research models.
Compare published assay incubation times for NAD+; overnight versus short pulses can invert apparent potency rankings in receptor assays.
Purity target ≥ 99.0% on the catalog is a specification goal—your QA team should confirm the specific lot COA meets internal thresholds before release.
NAD+ from Sulan Peptide Official is supplied for research use only (RUO)—not for human or veterinary use, diagnosis, or treatment. Direct specification or quotation questions via the Contact page or WhatsApp on sulanpeptide.shop.